Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type
about
Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphomaNew molecular insights into peripheral T cell lymphomasHow we treat chronic active Epstein-Barr virus infection.Diagnosis and management of extranodal NK/T cell lymphoma nasal type.MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencingGene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphomaHigh-resolution genome-wide analysis identified recurrent genetic alterations in NK/T-cell lymphoma, nasal type, which are associated with disease progression.Prognostic markers in peripheral T-cell lymphomaExtranodal natural killer/T-cell lymphoma, nasal type, involving the skin, misdiagnosed as nasosinusitis and a fungal infection: A case report and literature review.Exploring novel KDR inhibitors based on pharmaco-informatics methodology.Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targetsThe 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applicationsNonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation.Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma.An A91V SNP in the perforin gene is frequently found in NK/T-cell lymphomasAberrant antigenic expression in extranodal NK/T-cell lymphoma: a multi-parameter study from Thailand.Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addictionPRDM1 is a tumor suppressor gene in natural killer cell malignancies.An update on the management of peripheral T-cell lymphoma and emerging treatment optionsConcurrent Mutations in ATM and Genes Associated with Common γ Chain Signaling in Peripheral T Cell Lymphoma.The Genetic Deletion of 6q21 and PRDM1 and Clinical Implications in Extranodal NK/T Cell Lymphoma, Nasal TypeGlobal promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma.Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type.Epidemiological profiles between equol producers and nonproducers: a genomewide association study of the equol-producing phenotype.RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC.EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells.HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasmsHematolymphoid Lesions of the Sinonasal Tract.T-cell death following immune activation is mediated by mitochondria-localized SARM.Endogenous dendritic cells from the tumor microenvironment support T-ALL growth via IGF1R activation.S100A9 and ORM1 serve as predictors of therapeutic response and prognostic factors in advanced extranodal NK/T cell lymphoma patients treated with pegaspargase/gemcitabineMolecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets.Mutational Analysis of Extranodal NK/T-Cell Lymphoma Using Targeted Sequencing with a Comprehensive Cancer PanelThe downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type.Common variations within HACE1 gene and neuroblastoma susceptibility in a Southern Chinese population.Pathology and biology of peripheral T-cell lymphomas.Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).State of the art in natural killer cell malignancies.Targeted molecular therapy in peripheral T-cell lymphomas.Extranodal nasal type natural killer/T-cell lymphoma of testis: report of seven cases with review of literature.
P2860
Q26851166-AB466775-AA62-4987-AC73-90713A3B1C9CQ27026081-0E5560A7-6D7C-4DAE-B4CF-3CE2758DFF71Q30235902-11597BDA-9B24-4BF0-923F-0546012B9A20Q30249309-4D6DAE26-3CA2-4B28-8B4C-25A8613D3797Q31080906-1FD070F8-13E5-49A3-B083-744CCAC5201EQ33585243-D7077F68-2F7A-4208-8048-480B039BC443Q33839279-A2C36E38-CFF4-440F-8C55-9B51AEC33356Q34166857-9A493646-8E43-4245-87D9-24C0C86E5D80Q34293085-86E08BB5-6DA3-44DF-9E22-CEB3C539EB97Q34600778-4CEFDCCF-3E30-44B4-89B8-BD5504B28030Q34898306-ACD2CB1E-543F-49ED-A753-8DA7A1CE4084Q35029409-EB3A095F-0E26-4678-91F8-A2E332BC33B4Q35106969-9501F9FA-0850-40F4-B0B1-229543FF7953Q35107719-F9EE98D2-ECEC-4E22-8086-1E6AA7251A66Q35121514-3D347650-71E7-47DF-9A9E-4CE42A87ED19Q35207078-71441A66-3CA1-4929-943B-4BE9B5B03EE0Q35287869-D5B5FBB4-DEC5-439A-8FDD-43750B14F2D1Q35647475-AAD390C1-9F0A-4152-83D0-3E9AAD81F25CQ35683871-D056E7DD-EE6C-4540-AC8D-0EB1F1914490Q35832062-E5613679-2828-4720-AFE1-D7B6D4F37FD4Q35843927-F0B3C520-0140-4E4A-AC76-661D534265FEQ35859357-6FF00279-45FF-436E-A0AC-C481E2915E15Q36232164-DADACBB1-F819-4EEC-BB57-7B87A94D63FBQ36250137-E34E1A00-6547-4766-87CD-04A5C6C14300Q36259257-3FF7DF6F-5A79-4F9D-8959-3C220E9E41B9Q36323885-48D4726F-20FC-4625-8195-F18E7B418540Q36495194-50555014-49A7-4A2D-9958-0E66CCD48321Q36558579-55A2A27A-EA0F-4C22-9EEB-5B1EF0791681Q36603131-DF3B0239-5EFA-4BCB-B89F-1E5684C2E8BAQ36646371-F5FB879B-FD70-4714-B659-85AAAC8EAEF2Q36735918-E74BF1E8-4456-4F14-8A5F-D0BE0F51A357Q37187642-435620F4-A02E-4420-ADF8-816BA3493E3AQ37324841-90333938-79BC-4CF5-A2FF-AEA64F62594DQ37504355-6411E281-1A7C-4642-877E-6CAA1C7843DFQ37641476-B003008E-1761-4C50-A80A-D557F6F55FBDQ37831955-7ABA21BB-7F6B-4BE6-A463-C70DEFE5BF35Q37863688-42BCDF19-E9BB-42CA-920D-0F5DFEB31226Q37927210-5BB4C075-3EC6-4A18-A246-DBB853FCB8DDQ37937044-A6452C34-CB1E-4237-904D-9F2786575884Q37963470-8932EB99-9FE9-4A32-9A61-821F78401F5A
P2860
Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Gene expression profiling iden ...... NK/T-cell lymphoma, nasal type
@ast
Gene expression profiling iden ...... NK/T-cell lymphoma, nasal type
@en
type
label
Gene expression profiling iden ...... NK/T-cell lymphoma, nasal type
@ast
Gene expression profiling iden ...... NK/T-cell lymphoma, nasal type
@en
prefLabel
Gene expression profiling iden ...... NK/T-cell lymphoma, nasal type
@ast
Gene expression profiling iden ...... NK/T-cell lymphoma, nasal type
@en
P2093
P2860
P50
P1433
P1476
Gene expression profiling iden ...... NK/T-cell lymphoma, nasal type
@en
P2093
Barbara Petit
Bouchra Ghazi
Christian Schmitt
Emilie Thomas
Jacques Bosq
Jean-François Emile
Josette Brière
Marie-Hélène Delfau-Larue
Marion Travert
Nadine Martin-Garcia
P2860
P304
P356
10.1182/BLOOD-2009-05-221275
P407
P577
2009-11-30T00:00:00Z